Flagship explainer
How IMMUNITYBIO, INC. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $113M | 100% |
| |
| Cost of revenue | $753000 | 1% |
|
| $113M | 99% |
| |
| −$256M | −226% |
| |
| Income before tax | −$352M | −310% |
|
| Income tax | −$135000 | −0% |
|
| −$351M | −310% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001326110-26-000030